Anti-VEGF Treatment Resistant Pancreatic Cancers Secrete Proinflammatory Factors that Contribute to Malignant Progression by Inducing an EMT cell phenotype

PURPOSE: The resistance of tumors to antiangiogenic therapies is becoming increasingly relevant. There are currently no validated predictive biomarkers for selecting which cancer patients will benefit from antiangiogenic therapy. Also lacking are resistance biomarkers that can identify which escape...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Carbone, Carmine, Moccia, Tania, Zhu, Cihui, Paradiso, Genni, Budillon, Alfredo, Chiao, Paul J., Abbruzzese, James L., Melisi, Davide
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3178272/
https://ncbi.nlm.nih.gov/pubmed/21737511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-1185
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki